Literature DB >> 27794560

Molecular mechanisms underlying COPD-muscle dysfunction unveiled through a systems medicine approach.

Igor Marín de Mas1,2,3, Eric Fanchon4, Balázs Papp3, Susana Kalko5, Josep Roca2,6, Marta Cascante1,2.   

Abstract

MOTIVATION: Skeletal muscle dysfunction is a systemic effect in one-third of patients with chronic obstructive pulmonary disease (COPD), characterized by high reactive-oxygen-species (ROS) production and abnormal endurance training-induced adaptive changes. However, the role of ROS in COPD remains unclear, not least because of the lack of appropriate tools to study multifactorial diseases.
RESULTS: We describe a discrete model-driven method combining mechanistic and probabilistic approaches to decipher the role of ROS on the activity state of skeletal muscle regulatory network, assessed before and after an 8-week endurance training program in COPD patients and healthy subjects. In COPD, our computational analysis indicates abnormal training-induced regulatory responses leading to defective tissue remodeling and abnormal energy metabolism. Moreover, we identified tnf, insr, inha and myc as key regulators of abnormal training-induced adaptations in COPD. The tnf-insr pair was identified as a promising target for therapeutic interventions. Our work sheds new light on skeletal muscle dysfunction in COPD, opening new avenues for cost-effective therapies. It overcomes limitations of previous computational approaches showing high potential for the study of other multi-factorial diseases such as diabetes or cancer. CONTACT: jroca@clinic.ub.es or martacascante@ub.eduSupplementary information: Supplementary data are available at Bioinformatics online.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27794560      PMCID: PMC6544513          DOI: 10.1093/bioinformatics/btw566

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  50 in total

1.  Multistationarity, the basis of cell differentiation and memory. II. Logical analysis of regulatory networks in terms of feedback circuits.

Authors:  R. Thomas; M. Kaufman
Journal:  Chaos       Date:  2001-03       Impact factor: 3.642

Review 2.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

3.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

4.  Modeling genetic switches with positive feedback loops.

Authors:  Tetsuya Kobayashi; Luonan Chen; Kazuyuki Aihara
Journal:  J Theor Biol       Date:  2003-04-07       Impact factor: 2.691

5.  Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.

Authors:  Peter Plomgaard; Karim Bouzakri; Rikke Krogh-Madsen; Bettina Mittendorfer; Juleen R Zierath; Bente K Pedersen
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

6.  Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease.

Authors:  E Sala; J Roca; R M Marrades; J Alonso; J M Gonzalez De Suso; A Moreno; J A Barberá; J Nadal; L de Jover; R Rodriguez-Roisin; P D Wagner
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

7.  Mitochondrial dysfunction in COPD patients with low body mass index.

Authors:  R A Rabinovich; R Bastos; E Ardite; L Llinàs; M Orozco-Levi; J Gea; J Vilaró; J A Barberà; R Rodríguez-Roisin; J C Fernández-Checa; J Roca
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

8.  Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease.

Authors:  R A Rabinovich; E Ardite; T Troosters; N Carbó; J Alonso; J M Gonzalez de Suso; J Vilaró; J A Barberà; M F Polo; J M Argilés; J C Fernandez-Checa; J Roca
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

9.  Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

Authors:  Kalevi Pyörälä; Christie M Ballantyne; Barry Gumbiner; Michael W Lee; Arvind Shah; Michael J Davies; Yale B Mitchel; Terje R Pedersen; John Kjekshus
Journal:  Diabetes Care       Date:  2004-07       Impact factor: 19.112

10.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments.

Authors:  Rainer Breitling; Patrick Armengaud; Anna Amtmann; Pawel Herzyk
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

View more
  4 in total

1.  IL-13-driven pulmonary emphysema leads to skeletal muscle dysfunction attenuated by endurance exercise.

Authors:  Joseph Balnis; Tanner C Korponay; Catherine E Vincent; Diane V Singer; Alejandro P Adam; David Lacomis; Chun Geun Lee; Jack A Elias; Harold A Singer; Ariel Jaitovich
Journal:  J Appl Physiol (1985)       Date:  2019-11-27

2.  Network modules uncover mechanisms of skeletal muscle dysfunction in COPD patients.

Authors:  Ákos Tényi; Isaac Cano; Francesco Marabita; Narsis Kiani; Susana G Kalko; Esther Barreiro; Pedro de Atauri; Marta Cascante; David Gomez-Cabrero; Josep Roca
Journal:  J Transl Med       Date:  2018-02-20       Impact factor: 5.531

3.  Distinct skeletal muscle molecular responses to pulmonary rehabilitation in chronic obstructive pulmonary disease: a cluster analysis.

Authors:  Anita E M Kneppers; Roy A M Haast; Ramon C J Langen; Lex B Verdijk; Pieter A Leermakers; Harry R Gosker; Luc J C van Loon; Mitja Lainscak; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-18       Impact factor: 12.910

Review 4.  Personalized medicine for patients with COPD: where are we?

Authors:  Frits Me Franssen; Peter Alter; Nadav Bar; Birke J Benedikter; Stella Iurato; Dieter Maier; Michael Maxheim; Fabienne K Roessler; Martijn A Spruit; Claus F Vogelmeier; Emiel Fm Wouters; Bernd Schmeck
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.